Yiming Luo: Anti-β2GPI GWAS Reveals a Paradox in Thrombotic Mechanisms
Yiming Luo, Rheumatologist and Scientist at Columbia Medicine, shared a post on X:
”Our anti-β2GPI GWAS paper is now out! We found a paradox and a plausible explanation.
Our human genetics work re-capitulated the established model that Domain V binding to phospholipid is essential for anti-β2GPI-mediated thrombosis.
These findings have clinical application potentials, but large patient cohort studies are necessary to elucidate.”
ACR Journals shared a post on X about a recent article by Christophe Lalaurie et al., adding:
”A coding variant in APOH was associated with higher anti-β2-glycoprotein I antibody levels but lower venous thromboembolism risk.
Genetic and structural analyses suggest that altered phospholipid binding and epitope exposure may explain this paradox.
Molecular dynamics simulations of wild-type and W335S β2GPI (APOH) in a representative linear conformation (J-shape 2).”
Title: A Coding Single Nucleotide Polymorphism in β2-Glycoprotein I (APOH) is Associated with Increased Autoantibody Levels but Reduced Venous Thromboembolism Risk
Authors: Christophe Lalaurie, Lili Liu, Atlas Khan, Chen Wang, Stephen S. Rich, R. Graham Barr, Elana J. Bernstein, Krzysztof Kiryluk, Thomas McDonnell, Yiming Luo

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines
-
Nov 15, 2026, 20:50Asmaa Beltagy: Efficacy and Safety of Eltrombopag in SLE-Associated Immune Thrombocytopenia
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?